Breas Medical: Redefining Clinical Excellence

Top 10 Respiratory Devices Companies in Europe - 2020

Respiratory care devices are primarily used for diagnosis and treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. These devices provide enhanced care to patients suffering from acute and chronic respiratory diseases. Since the last decade, the increase in the prevalence of respiratory diseases is a pivotal factor that drives the respiratory care devices market. Currently, the European respiratory device market has been segmented based on product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. Added to that, the rising prevalence of chronic respiratory diseases due to the current situation caused by the COVID-19 pandemic is considered as one of the significant factors that augment the growth of respiratory device market in Europe. The increasing demand from chronic obstructive pulmonary disease (COPD), Sleep Apnea and asthma patients in the major economies of the region is favouring the growth of the regional market. Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region.

To help organizations across numerous vertical select the best options currently available in the market, MedTech Outlook has assessed and shortlisted the top respiratory devices solution providers that are at the forefront of providing cutting-edge technology solutions. These companies offer robust products coupled with innovative strategies that are distinctively prominent in the field. We present to you “Top 10 Respiratory Devices Solution Providers in Europe - 2020.”

Top Respiratory Devices Companies in Europe

Breas Medical

Breas is one of the global leaders in home mechanical ventilation, airway clearance and sleep therapy. The company follows an innovative and patient-centric approach in product design, and develops and manufactures products that pack state-of-the-art monitoring capabilities, making additional monitoring equipment almost unnecessary. Breas also develops CPAPs, ventilators and MIE devices, as well as a broad range of accessories and a connectivity solution, to help people with respiratory conditions in the hospital and at home. The Breas brands Vivo, Nippy, Clearway and Z1 are widely recognized and appreciated for their performance, ease of use and attractive design

Breathomix

Breathomix has developed BreathBase that allows assessment of the most probable diagnosis and can also be used for phenotyping individual patients and for predicting the response to (novel) interventions (tailored therapy). The missing link in breathomics provided by Breathomix B.V. is the combination of the easy to use eNose and an online reference database of exhaled biomarker profiles combined with validated clinical data that can be implemented at any location in the world. The online reference database is linked to a computer program based on artificial intelligence; BreathBase. The link with validated signal processing and machine learning algorithms allows real-time analysis of the obtained exhaled biomarker profiles. Lastly, BreathBase enables point-of-care personalized medicine by providing immediate diagnostic answers for the individual patient

Organis GmbH

Organis makes highly-realistic training possible through medical simulators that allow teaching clinicians in the use of their respiratory care products, and testing for manufacturers for development, production, marketing and regulatory affairs. Founded by experts in mechanical ventilation and mechatronics, Organis is on a mission to advance the field of medical simulation training by developing and manufacturing high-fidelity simulators. “Organis’ products are ‘artificial patients’ that can be treated as if they would be real patients– focused on respiratory care. In contrast to so-called ‘simulators’, Organis’ products are autonomous, i.e., they produce outcome autonomously and without operator interaction. Consequently, the outcome is highly reproducible

Electromag

Electromag SA, headquartered in Ecublens, Switzerland, is a leading expert in the development and manufacturing of brushless DC motors for demanding applications up to 300 W. One of the hallmark features of Electromag motors is their quietness and low vibration level for speeds up to 100’000 rpm. Renowned for their reliability, Electromag motors offer highest efficiency, in particular thanks to a patented winding technology. Electromag motors have been selected by leading medical device manufacturers in the fields of ventilation (hospital, transport, home care), dentistry (implantology, endodontics), orthopaedics and podiatry

GCE

The GCE Group is one of the world's leading companies in the field of gas control equipment having almost 100 years experience in the manufacture and supply of high pressure gas equipment. GCE operates in four different business areas: Cutting and Welding Technologies, Valves, Healthcare and Druva. Additionally, the company has more than 900 employees that represent the group with 20 subsidiaries, and representative offices worldwide. The headquarter is located in Malmo, Sweden. The main production units are situated in the Czech Republic, China and Poland

Innovis Health

Innovis Pharma, based in Athens, is a leading Greek pharmaceutical company that delivers high-quality, patient-centric healthcare solutions covering all major therapeutic areas. Innovis Pharma is committed to marketing medical solutions for treating patients and improving the quality of life for them and their families. Combining growing portfolio capabilities in generics & specialty brands, medical devices as well as specialized food supplements, Innovis Pharma is determinedly focused to delivering long term and sustainable results for patients, healthcare professionals and customers by investing on quality and on its employees

Leventon

Leventon, A Werfen Company was founded in 1979 to manufacture sterile and non-sterile disposable medical devices, based in Sant Esteve Sesrovires (Barcelona Area, Spain). Leventon is a worldwide leading position in IV therapy devices. The expansion on the international market started in 1986 with the entry of Spain in the European Community. At the beginning of the 90's, the international sales were 50% of the company's turnover. In 1993, an agreement to manufacture flow regulators under private label for a main player in the US market is signed, growing ever since. This international expansion has been consolidated every year, turning up to the current 87% of the turnover, from which almost 40% are USA sales, with Leventon distributors in more than 50 countries

Nyxoah

Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Nyxoah’s team is driven by the vision that OSA sufferers should benefit from the latest and greatest innovations, for better health outcomes, higher patient comfort and quality of life. At the heart of Nyxoah’s innovation is a unique neurostimulation technology with more than 160 patents submitted worldwide

PMD Solutions

PMD Solutions is a progressive company which is developing innovative patient friendly technologies to support health providers' early prevention model of patient care in the hospital environment. Currently PMD Solutions is developing an ubiquitously designed respiratory rate monitor with the vision of revolutionising traditionally used methods of manual and spot monitoring techniques through the adoption of our technology. Respiratory performance is a sensitive vital which varies accordingly with the varying health status of each patient. Fluctuations in a patient's respiratory performance can be the foremost indicator of emerging ailments. As such, these ailments can be efficiently treated before the patient is harmed

Spirohome

Spirohome helps both patients and enthusiasts of respiratory health to better understand, track, and proactively manage their lung health using a powerful digital health platform. Spirohome spirometers guarantee clinical-grade accuracy with every test, and the Spirohome app makes spirometry clear, quick and convenient for all users. Access to daily spirometry by patients with respiratory diseases such as asthma, COPD or cystic fibrosis can significantly improve the management of their diseases. Regular monitoring of lung health parameters can help reveal the effectiveness of treatments, make early detection of disease progression possible and help patients avoid unnecessary hospital visits